ESSA Pharma Inc (EPI):企業の財務・戦略的SWOT分析

【英語タイトル】ESSA Pharma Inc (EPI) - Financial and Strategic SWOT Analysis Review

Single User(1名様閲覧用)USD300 ⇒換算¥31,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥63,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥94,500見積依頼/購入/質問フォーム

Essa Pharma Inc (Essa Pharma) is a drug developer that offers oncology therapeutics. The company develops EPI-506, disrupts androgen receptor transcriptional activity through selectively blocking the N-terminal domain of the AR. It also conducts research on prostate cancer and the androgen receptor, metastatic CRPC, and the androgen receptor as a therapeutic target. Essa Pharma’s EPI-506 is used treat medical and surgical therapies that decrease androgen levels. The company has collaboration with the cancer prevention and research institute to advance science for cancer biology developments. It operates in Canada and the US. Essa Pharma is headquartered in Vancouver, British Columbia, Canada.

ESSA Pharma Inc Key Recent Developments

Feb 07,2019: ESSA Pharma provides corporate update and reports financial results for fiscal first quarter ended December 31, 2018
Dec 13,2018: ESSA Pharma provides corporate update and reports financial results for fiscal fourth quarter and year ended September 30, 2018
Aug 14,2018: Essa Pharma provides corporate update and reports financial results for fiscal third quarter ended June 30, 2018
May 14,2018: ESSA Pharma Announces Financial Results for Fiscal Second Quarter Ended March 31, 2018

This comprehensive SWOT profile of ESSA Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ESSA Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

ESSA Pharma Inc – Key Information
ESSA Pharma Inc – Overview
ESSA Pharma Inc – Key Employees
ESSA Pharma Inc – Key Employee Biographies
ESSA Pharma Inc – Key Operational Heads
ESSA Pharma Inc – Major Products and Services
ESSA Pharma Inc – History
ESSA Pharma Inc – Company Statement
ESSA Pharma Inc – Locations And Subsidiaries
ESSA Pharma Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

ESSA Pharma Inc – Business Description
ESSA Pharma Inc – Corporate Strategy
ESSA Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
ESSA Pharma Inc – Strengths
ESSA Pharma Inc – Weaknesses
ESSA Pharma Inc – Opportunities
ESSA Pharma Inc – Threats
ESSA Pharma Inc – Key Competitors

Section 3 – Company Financial Performance Charts

ESSA Pharma Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

ESSA Pharma Inc, Key Information
ESSA Pharma Inc, Key Ratios
ESSA Pharma Inc, Share Data
ESSA Pharma Inc, Major Products and Services
ESSA Pharma Inc, History
ESSA Pharma Inc, Key Employees
ESSA Pharma Inc, Key Employee Biographies
ESSA Pharma Inc, Key Operational Heads
ESSA Pharma Inc, Other Locations
ESSA Pharma Inc, Subsidiaries
ESSA Pharma Inc, Key Manufacturing facilities
ESSA Pharma Inc, Key Competitors
ESSA Pharma Inc, SWOT Analysis
ESSA Pharma Inc, Ratios based on current share price
ESSA Pharma Inc, Annual Ratios
ESSA Pharma Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

ESSA Pharma Inc, Performance Chart
ESSA Pharma Inc, Ratio Charts

★調査レポート[ESSA Pharma Inc (EPI):企業の財務・戦略的SWOT分析] (コード:DATA904C14968)販売に関する免責事項を必ずご確認ください。
★調査レポート[ESSA Pharma Inc (EPI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ